Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer

Published:2023-10 Issue: Volume:575 Page:216383
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Venkata Prabhakar Pitta,Jayamohan Sridharan^ORCID,He Yi,Alejo Salvador,Johnson Jessica D.,Palacios Bridgitte E.,Pratap Uday P.,Chen Yihong,Liu Zexuan^ORCID,Zou Yi,Lai Zhao,Suzuki Takayoshi,Viswanadhapalli Suryavathi,Weintraub Susan T.,Palakurthi Srinath,Valente Philip T.,Tekmal Rajeshwar R.,Kost Edward R.,Vadlamudi Ratna K.,Sareddy Gangadhara R.^ORCID

Funder

National Institutes of Health

American Cancer Society

National Institute of Neurological Disorders and Stroke

Elsa U. Pardee Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference62 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2018

2. Ovarian cancer statistics;Torre;Ca - Cancer J. Clin.,2018

3. Ovarian cancer;Matulonis;Nat. Rev. Dis. Prim.,2016

4. Epithelial ovarian cancer: evolution of management in the era of precision medicine;Lheureux;CA A Cancer J. Clin.,2019

5. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features;Prat;Virchows Arch.,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP